Trust Company of Vermont’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.47K | Hold |
1,000
| – | – | ﹤0.01% | 840 |
|
2025
Q1 | $8.04K | Hold |
1,000
| – | – | ﹤0.01% | 792 |
|
2024
Q4 | $8.98K | Hold |
1,000
| – | – | ﹤0.01% | 778 |
|
2024
Q3 | $7.33K | Hold |
1,000
| – | – | ﹤0.01% | 784 |
|
2024
Q2 | $5.71K | Hold |
1,000
| – | – | ﹤0.01% | 741 |
|
2024
Q1 | $5.01K | Buy |
+1,000
| New | +$5.01K | ﹤0.01% | 739 |
|
2023
Q4 | – | Sell |
-1,000
| Closed | -$7.77K | – | 807 |
|
2023
Q3 | $7.77K | Hold |
1,000
| – | – | ﹤0.01% | 676 |
|
2023
Q2 | $9.68K | Hold |
1,000
| – | – | ﹤0.01% | 679 |
|
2023
Q1 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 695 |
|
2022
Q4 | $4.32K | Hold |
1,000
| – | – | ﹤0.01% | 781 |
|
2022
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 748 |
|
2022
Q2 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 678 |
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$23K | – | 339 |
|
2021
Q4 | $23K | Buy |
+1,000
| New | +$23K | ﹤0.01% | 566 |
|
2021
Q3 | – | Sell |
-1,000
| Closed | -$13K | – | 329 |
|
2021
Q2 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 613 |
|
2021
Q1 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 604 |
|
2020
Q4 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 587 |
|
2020
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 563 |
|
2020
Q2 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 557 |
|
2020
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 600 |
|
2019
Q4 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 604 |
|
2019
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 821 |
|
2019
Q2 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 786 |
|
2019
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 750 |
|
2018
Q4 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 782 |
|
2018
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 861 |
|
2018
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 906 |
|
2018
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 818 |
|
2017
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 832 |
|
2017
Q3 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 779 |
|